Alaunos Therapeutics Inc

TCRT

NASDAQ. Currency in USD

0.61 -0.05 ( -7.08% )

Real time prices: December 09

Market Cap.
146.19M
Beta (5Y monthly)
0.18
Price/Earnings
-
EPS (TTM)
-0.19
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
1.25M
1y Target Est.
4.05
Day's Range
0.60
-
0.68
52 Week's Range
0.41
-
4.01

Historical Summary

Performance
EPS growth
Share Buybacks

About Alaunos Therapeutics Inc

Sector
Unknown
Industry
Unknown
Website
https://www.alaunos.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
0
Employees
41
Address
8030 El Rio Street, Houston, TX, United States, 77054
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors. Alaunos Therapeutics, Inc. has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; and a patent license agreement, and research and development agreement with the National Cancer Institute. The company was formerly known as ZIOPHARM Oncology, Inc. and changed its name to Alaunos Therapeutics, Inc. in January 2022. Alaunos Therapeutics, Inc. is headquartered in Houston, Texas.

Latest news

Here's Why Ziopharm (TCRT) Is a Great 'Buy the Bottom' Stock Now
Here's Why Ziopharm (TCRT) Is a Great 'Buy the Bottom' Stock Now

After losing some value lately, a hammer chart pattern has been formed for Ziopharm (TCRT),...
By Zacks Investment Research - 4 days ago

7 Penny Stocks To Watch With Unusual Options Activity, December 2022
7 Penny Stocks To Watch With Unusual Options Activity, December 2022

Penny stocks with unusual options activity. The post 7 Penny Stocks To Watch With Unusual...
By PennyStocks - 1 week ago

After Plunging 42% in 4 Weeks, Here's Why the Trend Might Reverse for Ziopharm (TCRT)
After Plunging 42% in 4 Weeks, Here's Why the Trend Might Reverse for Ziopharm (TCRT)

Ziopharm (TCRT) has become technically an oversold stock now, which implies exhaustion of the heavy...
By Zacks Investment Research - 1 week ago

Nasdaq Down 50 Points; Crude Oil Rises Over 1%
Nasdaq Down 50 Points; Crude Oil Rises Over 1%

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping...
By Benzinga - 1 week ago

US Stocks Turn Lower; Dow Falls Over 100 Points
US Stocks Turn Lower; Dow Falls Over 100 Points

U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 100...
By Benzinga - 1 week ago

Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday's Mid-Day Session
Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday's Mid-Day Session

Gainers Otonomy, Inc. (NASDAQ: OTIC) shares surged 74.2% to $0.1866. Otonomy recently posted a Q3...
By Benzinga - 1 week ago

Alaunos Therapeutics Announces Pricing of Public Offering of Common Stock
Alaunos Therapeutics Announces Pricing of Public Offering of Common Stock

HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq:...
By GlobeNewswire Inc. - 1 week ago

Why Elbit Systems Shares Are Trading Lower By Over 10%; Here Are 24 Stocks Moving Premarket
Why Elbit Systems Shares Are Trading Lower By Over 10%; Here Are 24 Stocks Moving Premarket

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares rose 26.3% to $0.7994 in pre-market trading after the...
By Benzinga - 1 week ago